Cost-Utility Analysis of Bosutinib for Previously Treated Chronic Myeloid Leukemia (Cml) in Portugal
Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.1695
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2014
Authors
Publisher
Elsevier BV